Close Menu

The Next Biotech

Ex Pfizer VP to Repeat Market Topping Drug Development with this ASX Stock?

As humans continue to live longer, certain diseases start to become more apparent, causing widespread concern for the elderly and their families. One of them is Alzheimer’s disease (AD) – a horrific disease that starts off with short-term memory loss and gradually progresses to severe memory failure including forgetting your own children and family.

Apr 20, 2016

MMJ Set to Boost Medical Cannabis Production Capacity by 1000%?

The market for medical cannabis is gradually moving out of the wilderness and onto government radars. The once forgotten medicine is currently being re-evaluated and reclassified in the US, Australia and Europe as its positive effect on a range of ailments is finally being rediscovered and decriminalised by governments across the globe.

Apr 1, 2016

Current Stocks